Health Condition 1: E114- Type 2 diabetes mellitus with neurological complications
Conditions
Interventions
Intervention1: Habb-e-Azaraqi: The ingredients of formulation are as follows:
Jawitri (Myristica fragrans) 29mg
Jaifal (Myristica fragnans) 29mg
Darchini (Cinamomoum zeylanicum) 29mg
Smagh e Arabi (
Sponsors
Department of Moalajat, Ajmal Khan Tibbiya College, Aligarh Muslim University, Aligarh
Eligibility
Inclusion criteria
Inclusion criteria: Clinically diagnosed patients of diabetic peripheral neuropathy with Type 2 diabetes mellitus through TCNS. Patients between the age of 30 to 60 years of age. Patients of either sex. Controlled case of Type 2 diabetes mellitus either by drug or life style modification. Fasting blood sugar less than or equal to 150 or HbA1c less than or equal to 8. Patients willing to participate in the study and follow the instructions. Washout period of 20 days for patient who were already taking any drug for neuropathy.
Exclusion criteria
Exclusion criteria: Patients below 30 years and above 60 years of age. Uncontrolled case of diabetes mellitus. HbA1c greater than 8. Physiological status: pregnancy and lactation Pathological status: cardiovascular diseases, renal diseases, hepatic diseases, thyroid dysfunction. Complications of diabetes mellitus other than diabetic peripheral neuropathy. Causes of neuropathy other than diabetes. Patient having ischaemic or neuropathic ulcer. Patients taking neurotoxic drugs. Clinically suspected cases of compressive neuropathy. Any comorbid condition. Alcoholics. Severe loss of vibration sensation. VPT value greater than 25 volts. Patients who refuse to give written consent for the study and who fail to follow up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement In Vibration Perception Threshold Value Grade 0 No Loss Of Vibration Perception-Complete Improvement Grade 1 Borderline Loss Of Vibration Perception-Slight Improvement. Grade 2 Mild Loss Of Vibration Perception-Partial Improvement. Grade 3 Moderate Loss Vibration Perception-No Improvement. Improvement In The Score For 10 Gram Monofilament.Timepoint: Assessment Of Vibration Perception Threshold Through Drp At Initiation Of Study (0 Day) And At The End Of Study (60 Days). 10 Miligram Monofilament Test At Initiation Of The Study (0 Day) And At The End Of Study (60 Days). | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement In The Subjective Parameters: Loss Of Light Touch And Temperature Sensation Numbness And Parasthesia Or Both In Feet And Hands Pain Symptoms Icluding Burning Allodynia (Contact Pain).Timepoint: Assessment On 0, 15, 30, 45 And 60 Days. | — |
Countries
India
Contacts
Public ContactTabi Idris Siddiqui
Ajmal Khan Tibbiya College, Faculty of Unani Medicine, Aligarh Muslim University, Aligarh
Outcome results
None listed